aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in the California Bay Area, JOINN Biologics is dedicated to advancing biotechnology and biopharmaceuticals through its premier contract development and manufacturing organization (CDMO) services. The company’s core mission is to support drug discovery and development by providing a comprehensive range of services from early-stage development to clinical manufacturing. JOINN Biologics focuses on biologics and advanced therapies, catering to biotech and pharmaceutical companies on a global scale.
Notable for its affiliation with the JOINN Family, which boasts over 20 years of success in drug discovery and development, JOINN Biologics has established itself as a key player in the industry. The company has achieved significant milestones in supporting numerous biotech and pharmaceutical projects, contributing to the advancement of innovative therapies. With a strong track record and a commitment to excellence, JOINN Biologics continues to make a substantial impact on the global healthcare landscape.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Biologics, CDMO
Technology
Biotech
Tags
Biotech
Model Types
Professional Services
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Joinn Biologics founded?
Joinn Biologics was founded in 2018.
Where is Joinn Biologics’s headquarters located?
Joinn Biologics’s headquarters is located in Richmond, CA, US.
When was Joinn Biologics’s last funding round?
Joinn Biologics’s most recent funding round was for $150M (USD) in August 2021.
How many employees does Joinn Biologics have?
Joinn Biologics has 375 employees as of Feb 4, 2024.
How much has Joinn Biologics raised to-date?
As of July 05, 2023, Joinn Biologics has raised a total of $210M (USD) since Aug 1, 2021.
Add Comparison
Total Raised to Date
$210M
USD
Last Update Aug 1, 2021
Last Deal Details
$150M
USD
Aug 1, 2021
Series B
Total Employees Over Time
375
As of Feb 2024
Joinn Biologics Address
2600 Hilltop Drive
Richmond,
California
94806
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts